Developing strategies to link basic cardiovascular sciences with clinical drug development: another opportunity for translational sciences. [electronic resource]
Producer: 20070727Description: 887-92 p. digitalISSN:- 0009-9236
- Animals
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents -- adverse effects
- Biomedical Research -- organization & administration
- Cardiovascular Diseases -- chemically induced
- Clinical Trials as Topic
- Cyclooxygenase 2 Inhibitors -- adverse effects
- Diffusion of Innovation
- Drug Evaluation, Preclinical
- Drug-Related Side Effects and Adverse Reactions
- Humans
- Purinergic P1 Receptor Antagonists
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.